Its common to experience a weight loss plateau during your journey, especially when you're gradually increasing your medication dose (known as titration)
Compared with the metformin plus sulfonylurea combination, the lowest risk for all three investigated endpoints, namely MACE, severe hypoglycemia, and all cause-mortality, was seen for people treated with metformin in combination with SGLT2is and GLP-1RAs (HR, 0.53 [95% CI, 0.350.80] for MACE
Our services are not intended to diagnose, treat, or manage medical conditions outside the scope of our programs
Understanding the evidence, knowing who should exercise caution, and recognising when to seek medical advice are essential for informed decision-making about GLP-1 therapy
The number of people with obesity with a BMI over 30 kg/m 2 in China is huge and still increasing yearly